drugset / Trial / NCT00916045

Pilot Study of Unrelated Cord Blood Transplantation

NCT00916045

Phase 2 Terminated 40 enrolled King's College Hospital NHS Trust
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety and feasibility of unrelated double and single cord blood transplantation in patients with haematological malignancies using reduced-intensity or myeloablative conditioning regimens.

Timeline

Start
2009-09
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified
Subject Melphalan Small molecule
Subject Thiotepa Other / unclassified
Background Busulfan Small molecule Intravenous
Background Cyclosporine Peptide
Background Fludarabine Small molecule
Background Mycophenolate Mofetil Small molecule
Background Thymoglobulin Protein / enzyme biologic